0001209191-17-032832.txt : 20170516
0001209191-17-032832.hdr.sgml : 20170516
20170516174319
ACCESSION NUMBER: 0001209191-17-032832
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170512
FILED AS OF DATE: 20170516
DATE AS OF CHANGE: 20170516
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cascadian Therapeutics, Inc.
CENTRAL INDEX KEY: 0001412067
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 260868560
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2601 FOURTH AVENUE
STREET 2: SUITE 500
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: (206) 801-2100
MAIL ADDRESS:
STREET 1: 2601 FOURTH AVENUE
STREET 2: SUITE 500
CITY: SEATTLE
STATE: WA
ZIP: 98121
FORMER COMPANY:
FORMER CONFORMED NAME: Oncothyreon Inc.
DATE OF NAME CHANGE: 20070927
FORMER COMPANY:
FORMER CONFORMED NAME: Biomira CORP
DATE OF NAME CHANGE: 20070911
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Myers Scott Dunseth
CENTRAL INDEX KEY: 0001356256
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33882
FILM NUMBER: 17849736
MAIL ADDRESS:
STREET 1: C/O ONOTHYREON INC.
STREET 2: 2601 4TH AVENUE, SUITE 500
CITY: SEATTLE
STATE: WA
ZIP: 98121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-12
0
0001412067
Cascadian Therapeutics, Inc.
CASC
0001356256
Myers Scott Dunseth
C/O CASCADIAN THERAPEUTICS, INC.
2601 4TH AVE., SUITE 500
SEATTLE
WA
98121
1
1
0
0
President and CEO
Common Stock
2017-05-12
4
P
0
2800
3.997
A
44216
D
The reported price in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $3.9969 to $3.9975 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Julia M. Eastland as attorney-in-fact for Scott D. Myers
2017-05-16